FCMV
IRON icon

Foresite Capital Management VI’s Disc Medicine IRON Stock Holding History

Foresite Capital Management VI’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$70.9K Buy
+970
New +$66.7K 0.01% 23

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Foresite Capital Management VI's IRON Position: Q2 2026 in Review

Foresite Capital Management VI opened a new position in Disc Medicine (IRON) in Q2 2026: 970 shares worth $70.9K. The stake represents 0.01% of the portfolio and ranks #23 among its holdings.

215 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Foresite Capital Management VI held 970 shares of Disc Medicine worth $70.9K as of Q2 2026.
  • Disc Medicine was a new Foresite Capital Management VI position in Q2 2026.
  • Disc Medicine made up 0.01% of Foresite Capital Management VI's portfolio in Q2 2026, its #23 holding.
  • 215 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Foresite Capital Management VI's 13F filing for Q2 2026, filed 14 Aug 2026.